Kolexia
Mary Florence
Gastro-entérologie
Hôpital Avicenne
Bobigny, France
98 Activités
111 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Adénocarcinome Syndrome du côlon irritable Maladies gastro-intestinales Tumeurs de l'estomac Tumeurs colorectales héréditaires sans polypose Récidive tumorale locale Métastase tumorale Constipation

Industries

IQVIA
36 collaboration(s)
Dernière en 2023
A+A
34 collaboration(s)
Dernière en 2023
B3TSI
30 collaboration(s)
Dernière en 2023
Amgen
12 collaboration(s)
Dernière en 2023

Dernières activités

AcSé CRIZOTINIB : Secured Access to Crizotinib for Patients With Tumors Harboring a Genomic Alteration on One of the Biological Targets of the Drug.
Essai Clinique (Unicancer)   26 février 2024
ADAGE: Randomised Phase III Study Evaluating Adjuvant Chemotherapy After Resection of Stage III Colonic Adenocarcinoma in Patients of 70 and Over Intergroup Trial: Ffcd, Gercor, Gerico, Unicancer-gi
Essai Clinique (Fédération Francophone de Cancérologie Digestive)   16 août 2023
Circulating tumour DNA at baseline for individualised prognostication in patients with chemotherapy-naïve metastatic colorectal cancer. An AGEO prospective study.
European journal of cancer (Oxford, England : 1990)   07 juin 2023
AAS-Lynch: Assessment of the Effect of a Daily Chemoprevention by Low-dose Aspirin of New or Recurrent Colorectal Adenomas in Patients With Lynch Syndrome
Essai Clinique (Assistance publique – Hôpitaux de Paris)   27 juin 2022
Prognosis and chemosensitivity of non-colorectal alimentary tract cancers with microsatellite instability.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   06 avril 2022
Chemotherapy use in end-of-life digestive cancer patients: a retrospective AGEO observational study.
Clinics and research in hepatology and gastroenterology   27 avril 2021
Prevalence and prognosis of microsatellite instability in oesogastric adenocarcinoma, NORDICAP 16-01.
Clinics and research in hepatology and gastroenterology   20 avril 2021
The Activity of Crizotinib in Chemo-Refractory MET-Amplified Esophageal and Gastric Adenocarcinomas: Results from the AcSé-Crizotinib Program.
Targeted oncology   13 avril 2021
Characteristics of patients with overlap functional gastrointestinal disorders.
Journal of gastroenterology and hepatology   20 février 2021
Psychological profiles of irritable bowel syndrome patients with different phenotypes.
Intestinal research   26 octobre 2020